Home
AbCellera

AbCellera Market Share Analysis for February 2026

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office.

Science and Education > Biology

Domainabcellera.com

Year Founded2012

Employees501 - 1000

Annual Revenue$200M - $500M

AbCellera

AbCellera (including company regionals)

abcellera.com

See more website traffic and engagement information

AbCellera Revenue up to February 2026 is 200M - 500M

revenue generated by AbCellera top domains

AbCellera top domains revenue over 3 years

Revenue for AbCellera top domains

abcellera.com200M - 500M

See more with Sales Intelligence

Total visits to AbCellera's top domains

Understand AbCellera market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

abcellera.com24.6K

See more with Sales Intelligence

Avg. visit duration in AbCellera's top domains

Analyze AbCellera engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

abcellera.com00:00:53

See more with Sales Intelligence

Avg. pageviews on AbCellera's top domains

See how AbCellera keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

abcellera.com2.95

See more with Sales Intelligence

AbCellera top competitors by domain

Top similar sites in February 2026, ranked by their affinity

vir.bioCompany NameVir BiotechnologyEmployees201 - 500HQUnited States, California, San FranciscoAnnual revenue$200M - $500MTotal visits49.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by AbCellera

These are the website technologies, by industry, used by AbCellera top domains

Advertising (9)

DoubleClick

Content Management System (4)

WordPress

Marketing (4)

Google Marketing Platform

Email Services (3)

G Suite

More Technologies

11

See all

News & Signals from AbCellera

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAbCellera Biologics Inc. attended event 44th Annual J.P. Morgan Healthcare Conference on Nov 13th '25.VANCOUVER, British Columbia - AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.

NewsAbCellera Biologics Inc. hires Stephen Quake as Board of Directors.AbCellera appoints Dr. Stephen Quake to its Board of Directors.

NewsAbCellera Biologics Inc. hired Sarah Noonberg as Chief Medical Officer on Sep 1st '25.Strengthening its leadership team, AbCellera Biologics Inc. (NASDAQ:ABCL) appointed Dr. Sarah Noonberg as Chief Medical Officer in September.